Published in Mol Biol Cell on June 01, 1996
Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J Cell Biol (2000) 3.63
EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion. J Cell Biol (2001) 2.46
Post-translational modifications in signal integration. Nat Struct Mol Biol (2010) 2.23
Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol Cell Biol (2004) 2.08
Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J (1997) 2.02
Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J Cell Biol (2001) 1.74
Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain. Mol Cell Biol (2002) 1.64
TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis. EMBO J (1998) 1.60
IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity. J Cell Biol (1999) 1.53
Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. J Cell Biol (2002) 1.35
Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signaling. J Cell Physiol (2008) 1.34
Recruitment and activation of phospholipase Cgamma1 by vascular endothelial growth factor receptor-2 are required for tubulogenesis and differentiation of endothelial cells. J Biol Chem (2003) 1.26
Autocrine epidermal growth factor signaling stimulates directionally persistent mammary epithelial cell migration. J Cell Biol (2001) 1.22
MAPK scaffold IQGAP1 binds the EGF receptor and modulates its activation. J Biol Chem (2011) 1.09
Sequential activation of phoshatidylinositol 3-kinase and phospholipase C-gamma2 by the M-CSF receptor is necessary for differentiation signaling. EMBO J (1997) 1.08
Epidermal growth factor signaling and mitogenesis in Plcg1 null mouse embryonic fibroblasts. Mol Biol Cell (1998) 1.04
Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline. Br J Cancer (2005) 1.00
ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease. Front Cell Neurosci (2013) 0.95
Stimulation of beta1-integrin function by epidermal growth factor and heregulin-beta has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase. Mol Biol Cell (1999) 0.93
Surface tethered epidermal growth factor protects proliferating and differentiating multipotential stromal cells from FasL-induced apoptosis. Stem Cells (2013) 0.93
Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells. J Biol Chem (2005) 0.92
Cellular migration and invasion uncoupled: increased migration is not an inexorable consequence of epithelial-to-mesenchymal transition. Mol Cell Biol (2014) 0.88
Regulation of phospholipase Cgamma in the mesolimbic dopamine system by chronic morphine administration. J Neurochem (1999) 0.87
The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL. Tissue Eng Part A (2013) 0.86
Developing a multiscale, multi-resolution agent-based brain tumor model by graphics processing units. Theor Biol Med Model (2011) 0.78
Fibrinogen binding to ICAM-1 promotes EGFR-dependent mucin production in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2009) 0.78
Insulin receptor-mediated signaling via phospholipase C-γ regulates growth and differentiation in Drosophila. PLoS One (2011) 0.78
Differential signaling of the GnRH receptor in pituitary gonadotrope cell lines and prostate cancer cell lines. Mol Cell Endocrinol (2013) 0.78
Targeting Protein Kinase C Downstream of Growth Factor and Adhesion Signalling. Cancers (Basel) (2015) 0.77
Retinoids arrest breast cancer cell proliferation: retinoic acid selectively reduces the duration of receptor tyrosine kinase signaling. Exp Cell Res (2004) 0.76
Protein modules and signalling networks. Nature (1995) 12.53
EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling. Cell (1989) 5.68
Strain-dependent epithelial defects in mice lacking the EGF receptor. Science (1995) 5.22
Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature (1995) 4.56
Protein kinase C isoenzymes: divergence in signal transduction? Biochem J (1993) 3.86
Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. Nature (1987) 3.75
Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther (1990) 3.55
Protein kinase C--a question of specificity. Trends Biochem Sci (1994) 3.14
Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. Science (1990) 2.92
Variants of 3T3 cells lacking mitogenic response to epidermal growth factor. Proc Natl Acad Sci U S A (1977) 2.65
Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci U S A (1993) 2.51
Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem Sci (1994) 2.38
Autophosphorylation and protein kinase C phosphorylation of the epidermal growth factor receptor. Effect on tyrosine kinase activity and ligand binding affinity. J Biol Chem (1985) 2.22
Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol (1994) 2.12
A glioma-derived PDGF A chain homodimer has different functional activities from a PDGF AB heterodimer purified from human platelets. Cell (1988) 1.99
Effect of phospholipase C-gamma overexpression on PDGF-induced second messengers and mitogenesis. Science (1990) 1.87
Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J Cell Biol (1994) 1.75
A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. Proc Natl Acad Sci U S A (1992) 1.70
Signal transduction and the actin cytoskeleton: the roles of MARCKS and profilin. Trends Biochem Sci (1992) 1.51
Epidermal growth factor (EGF) promotes phosphorylation at threonine-654 of the EGF receptor: possible role of protein kinase C in homologous regulation of the EGF receptor. J Cell Biol (1986) 1.42
Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Cancer Res (1992) 1.40
A negative feedback loop attenuates EGF-induced morphological changes. J Cell Biol (1991) 1.18
Phosphorylation of the epidermal growth factor receptor at threonine 654 inhibits ligand-induced internalization and down-regulation. J Biol Chem (1990) 1.14
Stimulation of epidermal growth factor receptor threonine 654 phosphorylation by platelet-derived growth factor in protein kinase C-deficient human fibroblasts. J Biol Chem (1987) 1.13
Transmembrane signaling by epidermal growth factor receptors lacking autophosphorylation sites. J Biol Chem (1993) 1.13
Signal transduction in c-met mediated motogenesis. EXS (1993) 1.10
Inhibitory effect of src homology (SH) 2/SH3 fragments of phospholipase C-gamma on the catalytic activity of phospholipase C isoforms. Identification of a novel phospholipase C inhibitor region. J Biol Chem (1992) 1.08
Role of threonine residues in regulation of the epidermal growth factor receptor by protein kinase C and mitogen-activated protein kinase. J Biol Chem (1993) 1.03
Constitutive phosphorylation of the epidermal growth factor receptor blocks mitogenic signal transduction. J Biol Chem (1991) 1.00
Proliferative response of fibroblasts expressing internalization-deficient epidermal growth factor (EGF) receptors is altered via differential EGF depletion effect. Biotechnol Prog (1994) 0.98
Protein kinase C-dependent phosphorylation of profilin is specifically stimulated by phosphatidylinositol bisphosphate (PIP2). Biochem Biophys Res Commun (1988) 0.96
Rapid and long-term effects on protein kinase C on receptor tyrosine kinase phosphorylation and degradation. J Biol Chem (1995) 0.94
EGF receptor activities in mammalian development. Mol Reprod Dev (1990) 0.92
Protein kinases in cellular signal transduction: tyrosine kinase growth factor receptors and protein kinase C. Cold Spring Harb Symp Quant Biol (1986) 0.88
Platelet-derived growth factor stimulates phosphorylation of growth factor receptor-binding protein-2 in vascular smooth muscle cells. J Biol Chem (1994) 0.88
Activation of protein kinase C inhibits human keratinocyte migration. J Cell Physiol (1993) 0.81
Growth factor-induced cell migration: biology and methods of analysis. Int Rev Cytol (1994) 0.81
Regulation of surface expression of high-affinity receptors for epidermal growth factor (EGF) in hepatocytes by hormones, differentiating agents, and phorbol ester. Dig Dis Sci (1992) 0.78
Prostaglandin F2 alpha decreases the affinity of epidermal growth factor receptors in Swiss mouse 3T3 cells via protein kinase C activation. FEBS Lett (1992) 0.77
Male attractiveness and differential testosterone investment in zebra finch eggs. Science (1999) 5.14
A competency model for general practice: implications for selection, training, and development. Br J Gen Pract (2000) 4.25
Cell adhesion and motility depend on nanoscale RGD clustering. J Cell Sci (2000) 4.13
Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J Cell Biol (2000) 3.63
Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond) (2008) 3.18
Tunable Fröhlich polarons in organic single-crystal transistors. Nat Mater (2006) 2.74
MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood (2001) 2.44
Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis. Arthritis Rheum (2010) 2.37
Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem (2000) 2.37
The septin CDCrel-1 binds syntaxin and inhibits exocytosis. Nat Neurosci (1999) 2.32
Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling. J Biol Chem (2001) 2.16
Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol (1994) 2.12
Interactions of Porphyromonas gingivalis with epithelial cells. Infect Immun (1993) 2.12
Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol (1998) 2.11
Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a. J Cell Biol (2000) 2.09
Phosphatidylinositol polyphosphate binding to the mammalian septin H5 is modulated by GTP. Curr Biol (2000) 2.09
Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol Cell Biol (2004) 2.08
A placebo-controlled trial of ketotifen (HC 20-511, Sandoz) in allergen induced asthma and comparison with disodium cromoglycate. Clin Allergy (1979) 1.98
Two psychological treatments for hypochondriasis. A randomised controlled trial. Br J Psychiatry (1998) 1.95
A survey of the demographics of blood use. Transfus Med (2007) 1.95
Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatr Serv (1999) 1.89
Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial. Am J Orthopsychiatry (1998) 1.78
Beliefs about worry and intrusions: the Meta-Cognitions Questionnaire and its correlates. J Anxiety Disord (1997) 1.76
Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer (2007) 1.75
Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J Cell Biol (1994) 1.75
Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J Cell Biol (2001) 1.74
Epidermal growth factor alters fibroblast migration speed and directional persistence reciprocally and in a matrix-dependent manner. J Cell Sci (1998) 1.72
Endoscopic optical coherence tomography based on a microelectromechanical mirror. Opt Lett (2001) 1.71
Engineering epidermal growth factor for enhanced mitogenic potency. Nat Biotechnol (1996) 1.68
EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCgamma signaling pathway. J Cell Sci (1998) 1.68
Expressed sequences from conidial, mycelial, and sexual stages of Neurospora crassa. Fungal Genet Biol (1997) 1.62
Biophysical integration of effects of epidermal growth factor and fibronectin on fibroblast migration. Biophys J (1999) 1.58
Effect of epidermal growth factor receptor internalization on regulation of the phospholipase C-gamma1 signaling pathway. J Biol Chem (1999) 1.57
EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clin Exp Metastasis (1996) 1.57
Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts. J Biol Chem (1999) 1.57
IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity. J Cell Biol (1999) 1.53
Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci U S A (1996) 1.51
Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys. Proc Natl Acad Sci U S A (2000) 1.50
Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan. J Cell Biol (1999) 1.50
Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma. Ann Oncol (2008) 1.49
The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull (2000) 1.47
3-D correlation-based speckle tracking. Ultrason Imaging (2005) 1.46
A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility. J Cell Biol (1996) 1.45
In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Hum Gene Ther (1996) 1.45
Galectin-1 prolongs survival of mouse liver allografts from Flt3L-pretreated donors. Am J Transplant (2013) 1.44
Does competitive employment improve nonvocational outcomes for people with severe mental illness? J Consult Clin Psychol (2001) 1.42
An unexpectedly rapid decline in the X-ray afterglow emission of long gamma-ray bursts. Nature (2005) 1.39
Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. Br J Cancer (2007) 1.39
STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J Biol Chem (1996) 1.35
Fatty acid-induced insulin resistance in adipocytes. Endocrinology (1997) 1.35
The actin-driven movement and formation of acetylcholine receptor clusters. J Cell Biol (2000) 1.34
The structural basis for the ligand specificity of family 2 carbohydrate-binding modules. J Biol Chem (2000) 1.33
Paths across generations: academic competence and aggressive behaviors in young mothers and their children. Dev Psychol (1998) 1.33
In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin Exp Metastasis (1995) 1.32
Evidence for synergy between family 2b carbohydrate binding modules in Cellulomonas fimi xylanase 11A. Biochemistry (2001) 1.31
Tumor invasion as dysregulated cell motility. Semin Cancer Biol (2001) 1.31
"Subclinical" pacemaker syndrome: a randomised study of symptom free patients with ventricular demand (VVI) pacemakers upgraded to dual chamber devices. Br Heart J (1992) 1.30
Agreements among traditional Chinese medicine practitioners in the diagnosis and treatment of irritable bowel syndrome. Aliment Pharmacol Ther (2004) 1.30
Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14. J Gen Virol (1995) 1.29
Postoperative cell mediated immune response is better preserved after laparoscopic vs open colorectal resection in humans. Surg Endosc (2003) 1.28
Structure of a family 15 carbohydrate-binding module in complex with xylopentaose. Evidence that xylan binds in an approximate 3-fold helical conformation. J Biol Chem (2001) 1.27
Localization of epidermal growth factor receptor in hepatocyte nuclei. Hepatology (1991) 1.27
Progression-free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assay. Int J Gynecol Cancer (2006) 1.25
A role for phospholipase C-gamma-mediated signaling in tumor cell invasion. Clin Cancer Res (1999) 1.25
Comparison of BD Vacutainer SST Plus Tubes with BD SST II Plus Tubes for common analytes. Clin Chim Acta (2001) 1.22
Job terminations among persons with severe mental illness participating in supported employment. Community Ment Health J (1998) 1.22
Ethnic differences in dietary intakes, physical activity, and energy expenditure in middle-aged, premenopausal women: the Healthy Transitions Study. Am J Clin Nutr (2001) 1.22
Brief cognitive therapy for panic disorder: a randomized controlled trial. J Consult Clin Psychol (1999) 1.22
Mathematical modeling of epidermal growth factor receptor signaling through the phospholipase C pathway: mechanistic insights and predictions for molecular interventions. Biotechnol Bioeng (2000) 1.21
Two large virion envelope glycoproteins mediate Epstein-Barr virus binding to receptor-positive cells. J Virol (1982) 1.21
Work and nonvocational domains of functioning in persons with severe mental illness: a longitudinal analysis. J Nerv Ment Dis (1997) 1.20
VAP-A binds promiscuously to both v- and tSNAREs. Biochem Biophys Res Commun (2001) 1.19
A negative feedback loop attenuates EGF-induced morphological changes. J Cell Biol (1991) 1.18
Kinetic and spectroscopic evidence for three actomyosin:ADP states in smooth muscle. J Biol Chem (2000) 1.18
Characterization and chromosomal localization of a new protein disulfide isomerase, PDIp, highly expressed in human pancreas. DNA Cell Biol (1996) 1.17
Reactions of police officers to body-handling after a major disaster. A before-and-after comparison. Br J Psychiatry (1991) 1.17
TBX6 null variants and a common hypomorphic allele in congenital scoliosis. N Engl J Med (2015) 1.15
Phosphatidylinositol-4-phosphate 5-kinase-1beta is essential for epidermal growth factor receptor-mediated endocytosis. J Biol Chem (2001) 1.14
IL-12, STAT4-dependent up-regulation of CD4(+) T cell core 2 beta-1,6-n-acetylglucosaminyltransferase, an enzyme essential for biosynthesis of P-selectin ligands. J Immunol (2001) 1.13
Characterizing hepatitis B stigma in Chinese immigrants. J Viral Hepat (2011) 1.13
Receptors for the complement C3d component and the Epstein-Barr virus are quantitatively coexpressed on a series of B-cell lines and their derived somatic cell hybrids. Cell Immunol (1982) 1.13
Prevalence of tendinitis and related disorders of the upper extremity in a manufacturing workforce. J Rheumatol (1990) 1.11
Renal advances in ultrasound elasticity imaging: measuring the compliance of arteries and kidneys in end-stage renal disease. Blood Purif (2005) 1.10
Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection. Int J Clin Pract (2007) 1.09
Insulin-like and insulin-inhibitory effects of monoclonal antibodies for different epitopes on the human insulin receptor. Biochem J (1987) 1.09
Determinants of 25-hydroxyvitamin D levels in African-American and Caucasian male veterans. Osteoporos Int (2009) 1.08
STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines. Br J Cancer (2006) 1.08
Uveitis and arthritis induced by systemic injection of streptococcal cell walls. Invest Ophthalmol Vis Sci (1986) 1.08
Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice. Virology (1997) 1.07
The topology of the substrate binding clefts of glycosyl hydrolase family 10 xylanases are not conserved. J Biol Chem (1998) 1.06
A novel method for diabetes diagnosis based on electronic nose. Biosens Bioelectron (1997) 1.05
Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death. J Immunol (2001) 1.04
The role of bacterial vaginosis in infection after major gynecologic surgery. Infect Dis Obstet Gynecol (1999) 1.04
Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha. J Cell Physiol (1996) 1.04
Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro. Life Sci (1999) 1.03
EGF receptor signaling in prostate morphogenesis and tumorigenesis. Histol Histopathol (1999) 1.02
Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors. J Biol Chem (2000) 1.02
Ligand-induced internalization and increased cell calcium are mediated via distinct structural elements in the carboxyl terminus of the epidermal growth factor receptor. J Biol Chem (1991) 1.02